OPKO Health Q2 2024 GAAP EPS $(0.01) Beats $(0.09) Estimate, Sales $182.200M Miss $185.190M Estimate
Portfolio Pulse from Benzinga Newsdesk
OPKO Health (NASDAQ:OPK) reported Q2 2024 GAAP EPS of $(0.01), beating the analyst estimate of $(0.09) by 88.89%. However, sales of $182.2M missed the $185.19M estimate by 1.61%, marking a 31.35% decrease from the same period last year.
August 07, 2024 | 9:06 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
OPKO Health's Q2 2024 GAAP EPS of $(0.01) beat expectations by 88.89%, but sales of $182.2M missed estimates by 1.61% and were down 31.35% YoY.
While OPKO Health's EPS beat expectations significantly, the miss on sales and the substantial YoY decline in revenue may offset the positive EPS news, leading to a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100